Johnson & Johnson's FcRn inhibitor nipocalimab has been awarded fast-track status by the FDA as a treatment for Sjögren's ...

Written by Nadia Arandjelovic] As the sun sets on another day of innovation and design at SJD World, we take a moment to ...

宾夕法尼亚州斯普林豪斯讯 - 强生公司（NYSE: ...

Johnson & Johnson JNJ announced that the FDA has granted a Fast Track designation (“FTD’) to its investigational drug, ...